Sagimet Biosciences Inc.

US$9.85As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SGMTHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (13.69%)
Div yield —
ROE (24.37%)
Biotechnology
Beta (5Y) 3.47
PE TTM —
TSR TTM 15.61%
Mkt cap US$698.5M
ROIC (16.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
7.30%
5.89%
Buy 2|0|11|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.17
0.17
0.19
26.50%
26.18%
24.06%
25.26%
Revenue$M
27.59
29.15
29.22
30.05
(4.15%)
4.06%
7.31%
11.59%
Peers (US$698.5M)
Cap (US$)
PE
689.7M
9.429x
Capital
TTM
5Y
10Y
Leveragex
1.223
0.135
0.142
EBIT/Intx
0.881
0.315
0.304
Own earn%
(3.89)
(46.48)
(42.88)
Sh yield%
26.70
25.35
24.85
Owners
Insiders/Inst%
3.96
26.68
Short interest%
3.68
SBC / revenue%
3.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
4–10
$1 testx
0.0
Incr. ROIC%
8